Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/17863
Title: Neuropeptides as Targets for the Development of Anticonvulsant Drugs
Authors: CLYNEN, Elke 
SWIJSEN, Ann 
RAIJMAKERS, Marjolein 
HOOGLAND, Govert 
RIGO, Jean-Michel 
Issue Date: 2014
Publisher: HUMANA PRESS INC
Source: MOLECULAR NEUROBIOLOGY, 50 (2), p. 626-646
Abstract: Epilepsy is a common neurological disorder characterized by recurrent seizures. These seizures are due to abnormal excessive and synchronous neuronal activity in the brain caused by a disruption of the delicate balance between excitation and inhibition. Neuropeptides can contribute to such misbalance by modulating the effect of classical excitatory and inhibitory neurotransmitters. In this review, we discuss 21 different neuropeptides that have been linked to seizure disorders. These neuropeptides show an aberrant expression and/or release in animal seizure models and/or epilepsy patients. Many of these endogenous peptides, like adrenocorticotropic hormone, angiotensin, cholecystokinin, cortistatin, dynorphin, galanin, ghrelin, neuropeptide Y, neurotensin, somatostatin, and thyrotropin-releasing hormone, are able to suppress seizures in the brain. Other neuropeptides, such as arginine-vasopressine peptide, corticotropin-releasing hormone, enkephalin, beta-endorphin, pituitary adenylate cyclase-activating polypeptide, and tachykinins have proconvulsive properties. For oxytocin and melanin-concentrating hormone both pro- and anticonvulsive effects have been reported, and this seems to be dose or time dependent. All these neuropeptides and their receptors are interesting targets for the development of new antiepileptic drugs. Other neuropeptides such as nesfatin-1 and vasoactive intestinal peptide have been less studied in this field; however, as nesfatin-1 levels change over the course of epilepsy, this can be considered as an interesting marker to diagnose patients who have suffered a recent epileptic seizure.
Notes: [Clynen, Elke; Swijsen, Ann; Raijmakers, Marjolein; Rigo, Jean-Michel] Hasselt Univ, Biomed Res Inst BIOMED, B-3500 Hasselt, Belgium. [Raijmakers, Marjolein; Hoogland, Govert] Univ Med Ctr Maastricht, Sch Mental Hlth & Neurosci, Dept Neurosurg, NL-6200 MD Maastricht, Netherlands.
Keywords: Animal seizure models; Antiepileptic drugs; Epilepsy; Febrile seizures; Neuropeptides; Seizures;animal seizure models; antiepileptic drugs; epilepsy; febrile seizures; neuropeptides; seizures
Document URI: http://hdl.handle.net/1942/17863
ISSN: 0893-7648
e-ISSN: 1559-1182
DOI: 10.1007/s12035-014-8669-x
ISI #: 000343157900029
Rights: © The Author(s) 2014. This article is published with open access at Springerlink.com.
Category: A1
Type: Journal Contribution
Validations: ecoom 2015
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
art%3A10.1007%2Fs12035-014-8669-x.pdf574.65 kBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

56
checked on Sep 3, 2020

WEB OF SCIENCETM
Citations

71
checked on May 22, 2022

Page view(s)

66
checked on May 26, 2022

Download(s)

96
checked on May 26, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.